- ... L, Wang JZ, Shan GL. Clinical efficacy and safety of huperzine A in treatment of mild to moderate Alzheimer ...
- ... Wang H, Wei ZH, et al. Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer’s disease: ...
- ... souvenaid versus placebo. 13.2.4.9.4. Huperzine A Very low- to low-quality evidence from ... with mild to moderate Alzheimer’s disease offered Huperzine A versus placebo or no intervention. Moderate-quality ...
- ... Souvenaid Cognition (post-intervention) ADCS-ADL (post-intervention) Huperzine A MMSE (post-intervention) ADL (post-intervention) BPSD ( ... 30 minutes long) Horvath 2013 Received a home safety toolkit, which included a booklet (keep the home ...
- ... Li WN, Yu HY (2011) The efficacy of Huperzine A in treating mild to moderate Data not ... Shi W, Chen XH (2013) Clinical study of huperzine A on patients with mild and moderate Alzheimer ...
- ... We found no eligible studies for Prevagen (apoaequorin), huperzine or phosphatidylserine. Our findings are mostly consistent with ... behavioral and psychological symptoms of dementia (BPSD), and safety? We identified several eligible trials that directly compared ...
- ... Liang XM, Juan W, et al. Treatment with Huperzine A improves cognition in vascular dementia patients. Cell ...
- ... interest (e.g., cannabinoids, ginseng, omega 3, gingko, huperzine A), a new comprehensive systematic review examining the ...
11 results